Commercialisation news
-
NewsFecal DNA testing could reduce global colonoscopy burden: experts
Experts gathered at the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium have highlighted the global challenge of limited access to colonoscopy, the gold standard for CRC screening.
-
NewsScientist devises test feed for fungal ‘micro-machine’ that breaks down wood
Researchers investigating a molecular machine found in fungi that decomposes wood into its basic components have come up with a test feed that allows them to observe its close-to-natural action, opening the door to putting it to industrial application.
-
NewsNew microbial fermentation manufacturing facility launched in Billingham
The UK’s life science sector has been bolstered by a £100m investment by FUJIFILM Diosynth Biotechnologies. This takes the form of a new microbial fermentation manufacturing facility in Billingham.
-
NewsUN publishes negotiation proposals for sharing benefits from plant, animal, microbial DNA sequences
New UN documents provide proposals and options to meet a global pledge to share fairly some of the multi-trillion-dollar revenues and other benefits derived from products related to the use of “digital sequence information on genetic resources (DSI)”.
-
NewsMicrobial agricultural inoculants market set to grow by $243.73 million from 2024-2028
The global microbial agricultural inoculants market size is estimated to grow by USD 243.73 million from 2024-2028, according to Technavio, with rising concerns over use of chemical fertilizers and pesticides in agriculture.
-
NewsScientists develop functional bread using probiotic yeast to help prevent asthma
Bread produced with probiotic yeast performed well in experiments with mice, showing potential to combat asthma, which affects 20 million Brazilians.
-
NewsBiodegradable ‘living plastic’ houses bacterial spores that help it break down
Researchers have developed a biodegradable form of thermoplastic polyurethane (TPU), filled with bacterial spores that, when exposed to nutrients present in compost, germinate and break down the material at the end of its life cycle.
-
NewsCarbon beads help restore healthy gut microbiome and reduce liver disease progression
Innovative carbon beads, invented by researchers at UCL, reduce bad bacteria and inflammation in animal models, which are linked to liver cirrhosis and other serious health issues. The study, published in Gut, found that the carbon beads, licensed to UCL-spinout Yaqrit, were effective in restoring gut health and had a ...
-
NewsChemists share secrets of faster, better kombucha fermentation
Chemists are investigating ways to reliably minimize alcohol, tailor taste profiles and speed up the kombucha fermentation process to help home and commercial producers optimize their funky brews.
-
NewsResearchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
NewsBacterial biotechnology to remove phosphorus from wastewater given funding boost
A novel bio-based process able to remove and recover phosphorus from wastewater – developed by Cranfield University experts – has won almost half a million pounds of funding from OFWAT.
-
NewsBiotech start-up BugBiome secures investment for research in sustainable pest protection
BugBiome, a biotech harnessing nature’s microbial defences for pest protection to benefit human and planet health, has successfully closed a pre-seed funding round, securing £310k from Cambridge Angels and Discovery Park Ventures.
-
NewsCARB-X funds Visby Medical to develop a portable rapid diagnostic for gonorrhea
Visby Medical aims to improve patients’ health outcomes and increase the lifespan of the last remaining antibiotic for resistant gonorrhea.
-
![RW703786[46]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/2/2/5422_rw70378646_994081.jpg)
NewsFA Bio secures £5.3m investment from Clean Growth Fund, Pymwymic and Ship2B Ventures
FA Bio, the British bio-tech company, has secured a £5.3 million tranche of investment from three European venture capital investment funds as well as existing shareholders and new private investors.
-
News‘UK should break licensing impasse and maximise the potential of phages’
The UK’s Science, Innovation & Technology Committee has called for steps to develop the potential of bacteria-killing viruses that can provide an alternative to antibiotics that are attracting growing resistance.
-
NewsSoil microbiome yields revolutionary new biofungicide
The Boyce Thompson Institute (BTI), a leader in plant science research, has announced that Ascribe Bioscience has partnered with Nutrien Ag Solutions to commercialize two crop protection products containing biofungicide Phytalix®.
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsUttam Superrhiza named as winner of Applied Microbiology International Product of the Year 2023
Mycorrhiza biofertilizer Uttam Superrhiza has been named as the winner of the Applied Microbiology International Product of the Year 2023.
-
![Pioneer Awards - Emmanuel Ladent, Carbios, and Jacques Playe, L'Oreal[88]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/7/4/8/4748_pioneerawardsemmanuelladentcarbiosandjacquesplayeloreal88_710603.jpg)
NewsCarbios and L’Oréal win Pioneer Award for world’s first enzymatically recycled cosmetic bottle
The Solar Impulse Foundation has recognised Carbios’ breakthrough innovation and its adoption in 2021 by L’Oréal with the world’s first fully enzymatically recycled plastic cosmetic bottle.
-
NewsFunding will advance production of phages to combat veterinary disease
Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost, aimed at advancing the production of phages to combat disease in the veterinary field and bring them to market.
